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The overuse and misuse of antibiotics for acute respiratory tract infections contribute to 
antimicrobial resistance and potential patient harm. The use of shared decision-making is an 
evidence-based practice tool shown to decrease unnecessary antibiotic prescriptions while 
promoting antibiotic stewardship. This quality improvement project implemented an 
evidence- based shared decision-making model, along with the use of an evidence-based 
decision tool for the treatment of acute respiratory infections in a rural college health center 
over a 4- month period. The results of this project were commensurate with the historical and 
current evidence found, adding to the body of knowledge and research supporting shared 
decision- making in the outpatient setting for the reduction in antibiotic use. 
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The Use of Shared Decision Making and its Effect on Antibiotic Prescribing 
Chapter 1 
Introduction and Background 
Antibiotic prescriptions for acute respiratory tract infections (ARI) in the outpatient setting are 
all too common. An estimated 44% of antibiotic prescriptions prescribed in the outpatient setting are 
for the treatment of acute respiratory tract infections including the common cold. Thirty percent of 
these are not necessary because the majority of ARIs are viral in nature (Pew Charitable Trust, 2016). 
Despite this consensus, greater than half of inappropriate antibiotic use is found to be in the outpatient 
setting (CDC, 2020). 
Background 
The inappropriate use of antibiotics is a leading contributor to antimicrobial resistance 
worldwide and is the root cause of numerous infections becoming resistant to current antimicrobial 
treatment, higher medical expenditures annually, and increased morbidity and mortality globally 
(WHO, 2012). Over two million Americans are diagnosed with an antimicrobial resistant infection 
annually. Clostridioides difficile is among the most common, leading to nearly 20, 000 deaths and 
healthcare expenses of over four billion dollars annually (CDC, 2015; The Whitehouse, 2014). 
The Problem 
In the United States, outpatient oral antibiotic prescriptions totaled nearly 259 million in 2018. 
Primary care physicians are among the heaviest prescribers accounting for over half of all outpatient 
antibiotic prescriptions (CDC, 2020). It has been identified that General Practitioners all too often 
succumb to prescribing antibiotics due to perceived patient expectations an inadequate knowledge, 




2007; Bakhit, Del Mar, Gibson & Hoffmann, 2018; Hruza et al., 2020; O’Connor, O’Doherty, 
O’Regan & Dunne, 2017). 
Antibiotic prescribing trends for acute respiratory infections in rural private residential college 
health center in Pennsylvania average was 28% per provider (See Table 1). Albeit there is no specific 
consensus on what percent of respiratory infections warrant antibiotics, it is understood that most of 
these infections are viral in nature, as previously stated. Based on the incidence of morbidity and 
mortality from antibiotic overuse and misuse, experts recommend a 50% reduction in prescriptions for 
ARIs by the year 2020 (Pew Charitable Trust, 2016). 
Population Affected 
Overuse of antibiotics affects millions of Americans worldwide annually. Over 60% of 
antibiotic prescriptions for viral infections are unnecessary, contributing to antibiotic resistance, and 
beckons for antibiotic stewardship (Hruza et al., 2020; Legare et al., 2010). The outpatient setting 
alone has been identified as promulgating antibiotic resistance through unnecessary antibiotic 
prescriptions (AHRQ, 2014). The mere use of antibiotics in one person potentiates antimicrobial 
resistance in the host that then may spread to family, friends, and community members (CDC, 2017). 
Epidemiology 
Antibiotic prescriptions in the United States are triple to that of European countries (Pew 
Charitable Trust, 2016). This is equivocal to approximately 838 prescriptions per 1000 persons (CDC, 
2015). Rates of secondary diarrheal infections, Clostridioides difficile, due to antibiotic use have 
increased among younger persons, once thought to be less susceptible. A majority of the data is from 
inpatient sources, which undoubtedly is missing a large proportion of unreported cases (DePestel & 




nearly 13, 000 die. Antibiotic use is the number one risk factor for acquiring this diarrheal infection 
(CDC, 2017). 
Antibiotic prescribing trends for acute respiratory infections in a small rural private residential 
college in Pennsylvania averaged 28% per provider (see Table 1). Over 50% of these prescriptions 
were not indicated at the time of diagnosis according to evidence-based practice guidelines. There was 
one incidence of Clostridioides difficile infection reported in 2018, by a student with a recent 
diagnosis of Crohn’s disease and history of three antibiotic prescriptions in a 12-month timeframe. 
What We Know 
The Whitehouse National Action Plan, pursuant to the Executive Order 13676, to reduce 
antibiotic resistance focuses in part on the adoption of evidence-based antibiotic stewardship strategies 
(The Whitehouse, 2014). Shared decision making (SDM) is one such strategy. Shared decision making 
is a process of communication between the provider and patient that encourages patient participation 
in decision making related to their care, with emphasis on their preferences (AHRQ, 2014). The use of 
shared decision making for the treatment of ARIs has been shown to reduce overall antibiotic 
prescriptions in the outpatient setting (Durante, McBride, Miklo, Killeen, & Creech, 2017; Sharp et 
al., 2017). Young adult patients prefer this decision-making model (Alden, Mers, & Akashi, 2012). 
Shared decision making has been an accepted and effective tool for the treatment of chronic 
conditions including heart failure and Type II Diabetes. In recent years, research on the use of shared 





More research is needed using various methods of shared decision making to evaluate its effect 
it has on antibiotic stewardship as well as other outcomes (Pew Charitable Trust, 2016). Specifically, 
research is needed in the college population as very few studies have been done, as evidenced by the 
lack of extensive data found for this project. College and university campuses provide a communal 
living setting, increasing the risk for infection(s) due to close quarters, shared living spaces, and 
shared common facilities. Similar to the outpatient setting, college health centers experience similar 
rates of ARI visit reasons. Therefore, promoting antibiotic stewardship by reducing the number of 
antibiotic prescriptions is indicated. Shared decision making is ideal for procuring this aim while 
teaching self-care and advocacy, a cornerstone of health promotion in higher education (ACHA, 
2014). 
Purpose Statement 
This quality improvement project asks whether the use of shared decision making in the 
treatment of acute respiratory tract infections in young adults age 18-24 reduces the number of 
antibiotic prescriptions. 
Clinical Questions 
 Will SDM be used for each ARI visit? 
 
 Will there be fewer antibiotic prescriptions for ARIs than pre-intervention? 
 
 Will the provided EBP guidelines be utilized for decision making 
DNP Project Objectives 
 To have at least 30 patients participate in SDM for the treatment of ARIs as evidenced by 




 To have both providers use EBP guidelines as a decision aid in the treatment of ARIs for each 
visit as documented in the EHR. 
 To promote antibiotic stewardship by using SDM and thus decrease the number of antibiotic 
prescriptions for ARIs by at least 20% from January 4, 2021-April 15, 2021, compared to 
January 4, 2019-April 15, 2019 
Assumptions and Limitations 
 This project assumes that the patients will consent to participation in the use of SDM for 
treatment of ARIs. 
 There is the possibility that patients will prefer the provider to decide treatment for ARIs. 
 There is the possibility that there will be a limited number of visits for ARIs due to the current 







Chapter Two includes a description of the theoretical framework and review of literature on 
shared decision making (SDM) in the treatment of acute respiratory tract infections (ARIs) in the 
outpatient setting. For the purpose of this project, acute respiratory tract infections include any 
infection lasting more than 2 days but less than 10, involving the upper airway, mouth, sinuses, ears, 
and throat (See Table 2). The Agency for Healthcare Research and Quality (AHRQ) SHARE 
Approach model for SDM will be employed during these visits (See Figure 1). The outpatient setting 
will be in a small rural private residential college health center in Pennsylvania, with a population of 
young adults ages 18-24. 
The literature search included English language original studies on shared decision making and 
acute respiratory infections in the outpatient setting. Databases included CINAHL, PubMed, Medline, 
and Google Scholar for original studies using the keywords “shared decision making”, “acute 
respiratory infections”, “outpatient”, and “antibiotic stewardship”. Date delimitations were January 
2009 to October 2020, as antibiotic stewardship did not garner much attention until the mid-2000s 
with the advent of the Affordable Care Act. The initial search yielded 199 studies. After applying 
inclusion criteria of adults age 18-40, peer reviewed, and antimicrobial resistance prevention, the list 
was narrowed to 28 studies. A major limitation is the lack of studies on this topic in the outpatient 
setting, which begs for future research. 
Theoretical Framework 
The Theory of Planned Behavior (TPB), originally the Theory of Reasoned Action in in health 




(Coronado-Vazquez et al., 2020). Although there are not many studies, a compelling systematic 
review of 20 studies based on TPB and intention to use SDM in general practice found providers 
preferred the use of SDM and intention to engage in the use of SDM was based most consistently on 
subjective norms, one of the three fundamental constructs of TPB. The three constructs are (a) 
attitudes- the degree to which a person has a negative or positive concept of an action/behavior; (b) 
subjective norm- beliefs about what peers approve/disapprove; (c) perceived behavioral control- a 
person’s perception or belief of ability and ease to perform an action/behavior, (Thompson-Leduc, 
Clayman, Turcotte, & Legare, 2014). The TPB theoretical framework will guide this quality 
improvement project providing the connection between how subjective norms, including patient 
preference, are most strongly correlated with providers’ intention to use SDM (Thompson-Leduc et 
al., 2014; Hruza et al., 2020; see figure 1). This socio-cognitive theory (TPB) supports the patient-
centered construct of SDM as the influence of patient preferences in the decision- making process is a 
leading predictor of adoption and use of SDM, (Thompson-Leduc et al., 2014). 
Antibiotic Resistance 
 The rate of antibiotic prescribing in the United States continues to remain constant. 
Inappropriate prescribing of antibiotics is the largest threat to antimicrobial resistance and 
development of resistant infections (Olesen, Barnett, MacFadden, Lipstich, & Grad, 2018; CDC, 
2015). Not only is overuse of antibiotics a known threat to antimicrobial resistance, lack of 
observation of EBP guidelines is an additional threat (Olesen et al., 2018). 
The incidence of antimicrobial resistance and superinfections due to inappropriate antibiotic use 
is daunting (CDC, 2020; The Whitehouse, 2014; WHO, 2012). Antibiotic associated diarrheal illness, 




community at large. Anyone taking an antibiotic is 7-10 times more likely to have Clostridioides 
difficile (CDC, 2017). The healthcare costs associated with Clostridioides difficile is in the billions 
annually (DePestel & Aronoff, 2013). With >80% of ARIs being viral in nature at the onset of 
presentation, the indication for antibiotic treatment is not present. Despite consensus, >60% of ARIs 
are treated with antibiotics initially (Hruza et al., 2020; Legare et al., 2010). Levofloxacin and 
azithromycin are two of the most prescribed antibiotics for ARIs at onset despite viral etiology 
(Olesen et al, 2018). 
Treatment of ARIs 
Evidence-based guidelines have been established for the treatment of ARIs. From specialty 
societies to the CDC, consensus has been formulated and readily available (See Table 3). Despite their 
availability, inappropriate prescribing patterns continue (CDC, 2015; Olesen et al., 2018). Some of the 
mainstay treatments for ARIs are symptom management using over-the- counter analgesics, 
decongestants, and mucolytics. Antibiotics are not considered one of these mainstay treatments. 
Antibiotic stewardship. Antibiotic stewardship was formalized in 2007 by the Infectious 
Disease Society of America (ISDA) and Society for Healthcare Epidemiology of America. It is 
comprised of a multidisciplinary team charged with formulating prescribing guidelines, monitoring 
prescribing patterns, and educating providers about appropriate antimicrobial use, among other things, 
to reduce the amount of antibiotics used and to foster appropriate use (Goff et al., 2017). The ISDA 
provides clinical guidelines for the treatment of a plethora of conditions, including ARIs. Despite 
these guidelines, antimicrobial resistance is on the rise (CDC, 2015; Goff et al, 2017). In response, the 
federal government appropriated monies to antibiotic resistance research in 2016. This led to the 




Shared decision making. Patient-centered care is a core element in SDM, with emphasis on 
patient values and preferences while working together to come to a treatment decision (AHRQ, 2014). 
Studies show patients under age 40, specifically young, educated adults, prefer the use of SDM in the 
treatment of ARIs (Blyer & Hulton, 2015; Briel et al., 2007). Evidence indicates active engagement in 
the treatment plan, along with a concise understanding of why the mutually determined treatment is 
appropriate, is appreciated by adult patients leading to greater satisfaction (Blyer & Hulton, 2015; 
Alden et al., 2012). Patient satisfaction is valuable, so much so that Medicare has established pay for 
performance incentives based on patient satisfaction scores. 
Primary care providers are integral in promoting judicious use of antibiotics. The evidence 
indicates providers that are trained in the use of SDM prescribe fewer antibiotics with reductions of up 
to 39% (Durante, Miklo, Killeen, & Creech, 2017; Legare et al., 2010; Little et al., 2019; Trivedi, 
2016). Initiation of a SDM approach to treatment affords opportunity to employ safe prescribing 
practices based on evidence, while considering patient preferences (Legare & Witteman, 2013). Its use 
has been shown to foster collaboration between provider and patient enhancing patient compliance to 
treatment, improved outcomes, and patient satisfaction (Legare & Witteman, 2013). 
Adoption. There are several factors contributing to the adoption of SDM. The influence of 
peers and their support for antibiotic stewardship in the form of SDM is fundamental. 
Providers were more likely to use SDM if peers were doing the same; it is the perception of intention 
of peers that was the common denominator across studies (Thompson-Leduc et al., 2014). Other key 
factors lending to adoption of SDM are training of healthcare providers in the use of SDM and the use 




The utilization of both, together, was consistent across studies evaluating successful implementation 
of SDM (Durante, et al., 2017; Legare et al., 2010; Little et al., 2019; Trivedi, 2016). 
Training formats were varied including chart reviews of historical prescribing patterns, 
internet- based education on communication skills to the use of leaflets, pamphlets, and decision aids. 
Overwhelmingly, the use of decision-aids was reported to enhance provider comfort in making 
treatment plans by decreasing indecisiveness, while increasing patient awareness of treatment options 
and appropriateness of treatment options. These findings were consistent across studies in varying age 
groups, mostly adults, some children. (Coronado-Vazquez et al., 2020; Sharp et al., 2017). Most 
decision aids were formulated based upon evidence-based practice guidelines. 
Barriers. Barriers identified were provider attitudes related to time, lack of knowledge of 
SDM, and diagnostic uncertainty (Coronado-Vazquez et al., 2020; Durante et al., 2017; Hruza et al., 
2020; Legare & Witteman, 2013; O’Connor et al., 2018). 
Provider attitudes reflected the belief time was insufficient to support SDM, a primary barrier 








Since the initiation of pay-for-performance, a term used to include initiatives aiming at health 
care quality improvement and value, providers are under pressure to meet quality measures 
during each patient care visit. Measures are comprehensive and can be time consuming, 
adding minutes to a typical 15-to-20-minute appointment, compounding any preconceived 
beliefs that patient visits are already too short. Provider education in SDM, predominantly by 
peers, improved the perception that it takes too much time and increased utilization of SDM 
across studies (Coronado-Vazquez et al., 2020; Hruza et al., 2020; Sharp et al., 2017). 
Specifically, training in communication with patients in pursuit of successfully engaging 
them in the SDM process was paramount (Legare & Witteman, 2013). 
Another common barrier was concern for poor patient outcomes should an antibiotic 
not be prescribed at the initial visit, the proverbial “what if…”. To address these barriers, 
studies were conducted to ascertain what interventions would help mitigate this issue. 
Findings were peer to peer education in the use of SDM, with emphasis on communication 
skills, most beneficial. Educating the patient when to follow up if their symptom does not 
resolve, or worsens, fostered confidence in quality outcomes. Thusly, patient self-advocacy 
and participation in care decisions enhanced provider confidence in SDM process. The 
addition of a decision aid led to improved provider comfort with fewer antibiotics prescribed, 
and greater patient understanding related to treatment plans. Decision aids are viewed as 
integral to the SDM process (Coronado-Vazquez et al., 2020; Hruza et al., 2020; Legare & 
Witteman, 2013; Sharp et al., 2017). 









heart failure and diabetes insofar as patient adherence to plan of care through education 
(AHRQ, 2014). Patient compliance taking antibiotics as directed can be tenuous at best, 
especially in the young adult population. Incorrect dosing in the form of not completing 
treatment as prescribed is contributory to antibiotic resistance (Olesen et al., 2018). 
Opportunity exists for the education of young adults about antibiotic stewardship for the 
treatment of ARIs using SDM and is preferred by most (Blyer & Hulton, 2016). Engaging 
young adults in risk/benefit conversation pertaining to their treatment cultivates self-
advocacy skills and increased health literacy, which are fundamental to SDM. 
Literature Gaps 
Although there are few studies utilizing SDM in the outpatient setting for the 
treatment of ARIs, as evidenced by the literature, its value is no less as it has been shown to 
decrease antibiotic prescriptions. That said, the duration of its effectiveness and utilization is 
brief in some studies and calls for duplicate studies for further validation (Briel et al., 2007; 
Durante et al., 2017; Hruza et al., 2020; Legare et al., 2010; Sharp et al., 2017). 
Studies focusing on the young adult, particularly those 18-24, are lacking (Alden et 
al., 2012; Blyer & Hulton, 2016). Considering the importance of antibiotic stewardship, the 
need for future studies including this age group is warranted. Opportunity to educate young 
adults, particularly in the college setting, are abundant. We know SDM works for the adult 
outpatient population, but not enough research has been done on the young adult. 
Despite the evidence that use of decision aids along with SDM leads to decreased antibiotic 








looked at its effect on the young adult patient (Alden et al., 2012; Briel et al., 2007; Durante 
et al., 2017; Legare et al., 2010).  
Therefore, a quality improvement project was conducted using AHRQ’s SDM model 
and CDC evidence-based guidelines as a decision tool for ARI visits in a small rural liberal 














This evidenced-based practice QI project implemented AHRQ’s SHARE Approach 
SDM model for the treatment of ARIs in a college health care setting. The need for this 
project was determined by the historical antibiotic prescribing rates for ARIs per provider in 
a small private rural college from January of 2019 to April of 2019. Out of 199 ARI visits, 61 
received antibiotics, which is approximately 31% (see Table 1). Benchmark data aims for 
less than 20% of ARIs be treated with antibiotics (The Whitehouse, 2014). An evidence-
based treatment decision aid for ARIs from the CDC was readily available in paper format 
for each provider (see Table 3). This QI project observed whether the use of SDM for the 
treatment of ARIs decreased the number of antibiotic prescriptions over a 15-week 
timeframe. In this project, additional time was added to each patient visit from 15 minutes to 
30 minutes per visit to afford adequate time engage patients in the use of SDM. 
Project Design 
This QI project design was chosen as it bridges the gap between identifying change 
needed on the patient level and procuring that change on a system-wide level (Toulany, 
McQuillan, Thull-Freedman, & Margolis, 2013). It was a pre and post study design. 
Project Population 
The project implemented purposeful sampling including English-speaking college 
students ages 18-23 attending a small private rural college. There were two Health Services 
providers, both were Certified Registered Nurse Practitioners (CRNP), and they gave verbal 








respiratory tract infections lasting less than 10 days were included. Exclusion criteria were 
students with a respiratory illness lasting greater than or equal to 10 days, follow-up 
appointments for an ARI, or a visit for reasons other than ARI symptoms. Purposeful 
sampling was utilized. 
Protection of Human Subjects 
All study participants read and signed an informed consent furnished by the Medical 
Assistant prior to the provider entering the visit (see Appendix A). IRB approval was 
received from Gettysburg College and exempt from West Chester University (see Appendix 
B). 
Setting 
The setting for this QI project was Health Services in a small private rural college in 
Pennsylvania. This health center is with a total of seven full-time employees, including two 
providers. Hours of operation are Monday through Friday from 8:00am to 5:00pm. 
Timeline 
This QI project commenced February 4, 2021 and ended May 15, 2021. Please see table 
4 for timeline details. 
Education and Data Collection 
After IRB approval beginning January 15, 2021, both CRNP providers completed the 
AHRQ SHARE Approach SDM 3-hour online webinar. There was no fee for this webinar 








with the IT Administrator occurred prior to the January 15th date to imbed the SDM model 
and CDC EBP guidelines into the EHR (See Table 4). 
Data Analysis 
Upon completion of the project, the data was shared with a statistician for description 
and inferential statistical analysis. Data was collected through chart review for specific ARI 
diagnosis codes in the EHR. The use of SDM and EBP for each ARI visit were documented 
by marking a specific cell in the objective portion of the visit note and were captured through 
reports generated by the IT Administrator. Lastly, each ARI visit plan was reviewed for 
identification of antibiotic prescription or not. Data analysis was conducted using SPSS odds 
ratio to compare preintervention and postintervention prescribing rates. As the average 
prescribing rate preintervention was not as high as National average reported, the overall goal 
of the project was to not exceed previous trends with end-goal of reducing antibiotic 
prescription numbers postintervention. 
Barriers 
The main barrier was mainly related to the de-densification of the campus population 
due to the COVID-19 pandemic. The total campus population was decreased in the Spring 
2021 semester from 2, 600 students to 1,500. Thus, fewer patient care visits for ARIs were 
likely. 
Another barrier identified was consent forms were forgotten by the support staff. The 
forms were originally kept at the front desk where students check-in. To overcome this, 











Data collection commenced in September 2020 for historical antibiotic prescribing 
rates for ARIs. Timeframe of this data was August 2018 to May 2019. Data collection for 
current ARI visits and antibiotic prescribing rates commenced February 4, 2021. This data 
includes the use of AHRQs SHARE Approach model and CDC EBP guidelines for ARI 
treatment. Final data collection ended April 15, 2021. 
Patient Demographics 
 There was a total of 246 patients seen during the preintervention and postintervention 
period combined. Of the 246, 148 were female and 88 were male. During the intervention 
period, 31 were female and 16 were male. 
Response Rate 
Of the 49 students asked to participate in this QI project, 47 agreed to sign the consent. 
This was determined by the number of ARI diagnosis codes during the project period, 
including additional diagnoses were added to compensate for decreased visits due to the de-
densified campus second to Covid pandemic, and number of signed consents received. One 
of the consents not signed was missed by the support staff unbeknownst to the provider, and 
the other patient did not agree to sign. Data from both visits was left out of results. The data 
was retrieved from the EHR, and then physically reviewed in the EHR manually to match 










The latest version of SPSS (SPSS 27.0) was used for statistical analysis. The data 
analysis plan was conducted in three phases. First, all study variables were presented using 
descriptive statistics. Second, bivariate analysis, specifically single predictor binary logistic 
regression analysis was used to identify which explanatory variables (timepoint, provider, 
acute respiratory infection diagnosis) were related to the dependent variables at a statistically 
significant level (p<.05). Explanatory variables that evidenced a significant relationship with 
a dependent variable, rates of Antibiotic Prescribed (Yes/No), were included in the third 
phase of analysis, multivariate analysis. Third, a multivariate model, specifically a binary 
logistic regression model was used to model changes in rates of Antibiotic Prescribed 
(Yes/No) from pretest to posttest. Due to conceptual considerations, the explanatory variable 
respiratory infection diagnosis was controlled for in the final regression model even if there 
was not a significant bivariate relationship between these variables. 
Checks of test assumptions for the binary logistic regression model indicated that 
multicollinearity was not a problem between the 2 explanatory variables (VIF=1.16). In 
terms of statistical power, the Power and Precision software program indicated that a binary 
logistic regression model (estimating experiencing the dependent variable at approximately 
half at pretest and one-quarter at posttest), a medium effect size (OR= 3.34) would be 
detected with 100 study participants. Thus, the current sample of 246 study participants 
provides sufficient statistical power for the current analysis. 
Research question. In college-age students, does the use of shared decision-making 








Table 3 presents a binary logistic regression analysis that indicates that pretest and 
posttest timepoints were significantly related to the Antibiotic Prescription rate, B=-1.01, 
SE=.50, Wald X²=4.79, p<.05, where study participants at posttest were 3.0 (1/.33=3.0) times 
less likely to evidence an Antibiotic Prescription relative to those at pretest. 
Descriptive analysis. Table 5 presents a descriptive analysis of study variables. There 
were 246 study participants involved in the current study. Data regarding the variable 
timepoint, pretest included 80.9% (n=199) of the sample, while posttest included 19.1% 
(n=47) of the sample. Among providers, CD addressed 19.5% (n=48) of cases, while JF 
addressed 80.5% (n=198) of cases. Lastly, only 3.3% (n=8) did not have a diagnosis of an 
acute respiratory infection diagnosis. 
Bivariate analysis. Table 6 presents a single predictor binary logistic regression 
analysis examining Antibiotic Prescribed (Yes/No) by pretest/posttest timepoint, provider, 
and severe respiratory diagnosis. Analysis indicated that the dependent variables were not 
significantly related to the variables provider, B=.61, SE=.40, Wald X²=2.31, OR=1.84, 95% 
CI=.84-4.04, p=.13, and acute respiratory infection diagnosis, B=-.14, SE=.83, Wald X²=.03, 
OR=.87, 95% CI=.17-4.41. The dependent variable was significantly related to the variable 
timepoint, B=-.93, SE=.44, Wald X²=4.48, OR=.40, 95% CI=.17-.93, p<.05, where study 
participants at posttest (14.9% received prescriptions) were 2.5 (1/.40=2.5) times less likely 
to evidence an Antibiotic Prescription relative to those at pretest (30.7% received 
prescriptions). 
Multivariate analysis. Table 7 presents a binary logistic regression analysis examining 








respiratory infection diagnosis. Data indicated that the overall model was statistically 
significant, 
X²(2)=5.90, p<.05, and classified 72.4% of cases correctly. Within the model, timepoint was 
significantly related to the dependent variable, B=-1.01, SE=.50, Wald X²=4.79, p<.05, 
where study participants at posttest were 3.0 (1/.33=3.0) times less likely to evidence an 















This quality improvement project sought to find if the use of SDM for the treatment 
of ARIs would in fact decrease the number of antibiotic prescriptions. This was achieved by 
comparing preintervention ARI visits in a college health center to postintervention ARI visits 
in the same health center, for the same two Nurse Practitioner providers. The findings 
support the use of SDM for the treatment of ARIs to promote antibiotic stewardship and 
indicate antibiotic prescriptions were three times less likely to be given compared to 
historical data provided. 
Sample 
One surprising finding was the proportion of female patients versus male patients. In 
both the preintervention and postintervention data sets, females outnumbered males by 
approximately 50%. One factor that may have influenced this is the proportion of female 
students at the college compared to male students. Another factor may be the de-densification 
of the campus resulting in more female students. 
Results 
The findings in this project support the evidence that the use of shared decision 
making for the treatment of ARIs has been shown to reduce overall antibiotic prescriptions in 
the outpatient setting (Durante et al., 2017; Sharp et al., 2017). Engaging the patient in 








options while supporting their self-advocacy. One objective of this study was to engage in 
open discussion with patients using SDM and was successfully done for each ARI visit. 
Another objective was to decrease the number of antibiotics prescribed for ARI visits by 
50%, a national benchmark. This goal was met as evidenced by the pre and post data results, 
30.7% and 14.9% respectively, a 50% decrease achieved. Interestingly, these findings were 
more robust than that of some of the previous studies where reductions in antibiotic 
prescribing were as high as 39% (Durante et al., 2017; Legare et al., 2010; Little et al., 2019; 
Trivedi, 2016). This may be due to the size of this project being on a smaller scale. 
It is important to note that in the post intervention analysis, there were seven 
antibiotics prescribed out of 47 visits. Of the seven prescribed, two were for non-ARI visit 
reasons. The use of SDM was used in all visits. Of the seven prescriptions, six met EBP 
guidelines for use. This finding is commensurate with studies indicating the use of a decision 
aid enhances the use of SDM in providing reassurance (Legare & Witteman, 2013). 
Theoretical Framework 
The findings fit the Theory of Planned Behavior model. The use of SDM was 100% in 
the project. Providers were trained in its use and shared a positive attitude toward its use. The 
intention to use SDM for each visit was influenced by the subjective norm, or perceived 
approval, which is the most critical construct of TPB. Adequate training of key stakeholders 
was fundamental in influencing both attitudes and subjective norm. The providers also used 
EBP guidelines consistently, which provided enhanced control over the decision making for 









Implications and Limitations 
The implications for practice for providers are that SDM can be used consistently for 
ARI visit reasons to support antibiotic stewardship and avoid undue potential harm. Every 
time an antibiotic is prescribed, antimicrobial resistance is triggered. Consistent support for 
SDM will encourage adoption by peers and provide patients opportunity to be educated about 
treatment options while self-advocating. 
Future implications for this project are to incorporate the use of SDM for additional 
diagnoses. Opportunities to include the patient in their care and treatment plans fosters 
greater satisfaction and adherence to the plan of care (Legare & Witteman, 2013). 
Limitations in this study include the missed opportunity to use SDM due to decreased 
visits second to the pandemic. The project itself was small and included only two providers. 
Another limitation was the missed opportunity due to staff forgetting to have consent signed. 
This was surmounted by placing consents in the patient room door pocket, along with a 
written reminder sign on the door. Although not necessarily a limitation, the fact that far 
more female patients presented for ARI visits than males, begs for further investigation. 
In conclusion, the outcomes of this project indicate that SDM is an effective 
intervention that reduces the use of antibiotics for ARIs. After education in AHRQ’s SHARE 
Approach Model for SDM, the providers adopted its use for every ARI visit, as well as seven 
other visit- types. Patients generally were agreeable to participate, almost 100%. At the end 
of each visit, their preferences were heard, treatment education was provided in the form of 
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Number of ARI visits from 01/21/19- 
04/15/19 
Provider CD (12 hours per week) total- 48 








Total antibiotic Rxs 


















J20.9 Acute bronchitis 
J02.9 Acute pharyngitis 
J01.90 Acute sinusitis 
H66.90 Otitis media 
H65.90 Unspecified nonsuppurative 
otitis media 
H60.90 Otitis Externa 
J00 Acute nasopharyngitis 
J03.90 Tonsillitis 














Table 3. Evidence-based guidelines from CDC for acute respiratory infections 
 






















 About 1 out 

























 Diagnose acute 
bacterial rhinosinusitis 
based on symptoms that 
are: 
o Severe (>3-4 






o Persistent (>10 
days) without 
improvement, 




o Worsening (3- 








a viral upper 
respiratory 
infections 
(URI) lasting 5- 
6 days. 







If a bacterial infection is 
established: 
 
 Watchful waiting is 
encouraged for 
uncomplicated cases for 
which reliable follow- 
up is available. 
 Amoxicillin or 
amoxicillin/clavulanate 
is the recommended 
first-line therapy. 
 Macrolides such as 
azithromycin are not 
recommended due to 




 For penicillin-allergic 




















 Evaluation should focus 
on ruling out 
pneumonia, which is 
rare among otherwise 
healthy adults in the 
absence of abnormal 
vital signs (heart rate ≥ 
100 beats/min, 
 
Routine treatment of 
uncomplicated acute bronchitis 
with antibiotics is not 














respiratory rate ≥ 24 
breaths/min, or oral 
temperature≥ 38 °C) 




 Colored sputum does 
not indicate bacterial 
infection. 
 For most cases, 
chest radiography is 
not indicated. 
 
Options for symptomatic therapy 
include: 
 










Evidence supporting specific 




























two to four 
colds 
annually. 






























symptom relief of nasal 
symptoms and cough. 
 Non-steroidal anti- 
inflammatory drugs can 
be given to relieve 
symptoms. 





nasal saline irrigation 
as effective treatments 











Providers and patients must weigh 
the benefits and harms of 
symptomatic therapy. 
 










Table 4. Timeline 
Completion Date Planning Pre- 
implementation 
Implementation Evaluation 





   
11/08/20  Submit 
IRB applications 
  







01/27/21  Meet with IT to 
add SDM & EBP 
check boxes to 
“objective” in 
SOAP note in 
EHR; provide NPs 





01/28/21  Pilot test 
documentation of 




01/29/21   Begin tracking 
ARI visits, use of 
SDM and EBP 
guidelines 
 
04/15/21    Meet with 
statistician; 
evaluate data 
and write analysis 










Table 5. Descriptive Analysis of Study Variables (n=246) 
 
Variable n % 
Timepoint 
  
Pretest 199 80.9 
Posttest 47 19.1 
Provider   
CD 48 19.5 
JF 198 80.5 
Acute Respiratory Infection Diagnosis 
Yes 238 96.7 






















Table 6. Single Predictor Binary Logistic Regression Analysis Examining Antibiotic 











Variable n (%)  n (%)  B (SE) Wald X² OR (95% CI) p 
Timepoint       -.93 (.44) 4.48 .40¹ (.17-.93) .03 
Pretest 138 (69.3) 61 (30.7)     
Posttest 40 (85.1) 7 (14.9)     
Provider   .61 (.40) 2.31 1.84 (.84-4.04) .13 
CD 39 (81.3) 9 (18.8)     
JF 139 (70.2) 59 (29.8)     
Acute Respiratory Infection Diagnosis -.14 (.83) .03 .87 (.17-4.41) .87 
Yes 172 (72.3) 66 (27.7) 
No 6 (75.0) 2 (25.0) 
¹The inverted odds ratio reflects a value of 2.5 (1/.40=2.5) times less likely to evidence an 









Table 7. Binary Logistic Regression Analysis Examining Antibiotic Prescribed (Yes/No) 









-.82 (.95) .75 .44 (.07-2.82) .39 
 
 
Timepoint -1.01 (.50) 4.79 .33¹ (.12-.89) .03 
 
Model: X²(2)=5.90, p<.05, 72.4% of Cases Were Classified Correctly 
¹The inverted odds ratio reflects a value of 3.0 (1/.33=3.0) times less likely to evidence an 















Figure 1. The SHARE Approach a communication tool that guides providers and patients 
through exploration of risk and benefits for healthcare treatments with focus on patient 


























































Consent to Participate in the Project of the Use of Shared Decision Making for the Treatment of Acute 
Respiratory Tract Infections 
Identification of Study Investigator and Purpose of Project 
You are being asked to participate in a project conducted by Jennifer M. Fernandes, MSN, FNP, from 
West Chester University. The purpose of this project is to assess the use of shared decision making in 
the treatment of acute respiratory tract infections and its effect on antibiotic prescribing rates. 
Project Procedures 
Should you decide to participate in the project you will be asked to sign this consent form prior to 
answering any questions. You may opt out of the project at any time without affecting your 
care/treatment. The project consists of the provider using the AHRQ SHARE Approach shared 
decision making 5-step model during your acute care visit. You will be asked to engage in the shared 
decision making for the treatment of your acute respiratory symptom(s). Visits are 30 minutes in length 
and will not go over this time, in most cases. You may request for the provider to make all decisions 
regarding your treatment if you are not comfortable with the shared decision-making process. Your 
treatment will be guided by the Centers for Disease Control and Prevention evidence-based guidelines 
for the treatment of acute respiratory tract infections. 
Confidentiality 
Participation in the project is confidential. No personal identifiers will be used; gender and age will be 
tracked. Your patient visit is protected under the Health Insurance Portability and Accountability Act 
(HIPAA). 
Risks 
The investigator does not perceive any more than minimal risk by participating in this project (no more 
risk than one may experience in daily life). 
Benefits 
There are no perceived benefits from participation in this project other than it might provide increased 
understanding of appropriate use of antibiotics for acute respiratory tract infections and may help 
others with similar symptoms in the future. 
Contact Information for IRB Regarding Your Rights 
Jennifer Fernandes, MSN-FNP, Health Services:  
jfernand@getttsburg.edu 













   
   
   
   
   
   
  
